Conditional relative survival in Waldenström's macroglobulinaemia: a population-based study in The Netherlands

Karima Amaador; Marie José Kersten; Otto Visser; Eduardus F.M. Posthuma; Monique C. Minnema; Josephine M.I. Vos; Avinash G. Dinmohamed

doi:10.1111/bjh.17926

Conditional relative survival in Waldenström's macroglobulinaemia: a population-based study in The Netherlands

Karima Amaador^*
, Marie José Kersten
, Otto Visser
, Eduardus F.M. Posthuma
, Monique C. Minnema
, Josephine M.I. Vos
, Avinash G. Dinmohamed

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

7 Downloads (Pure)

Abstract

Contemporary diagnosed WM patients, compared to the general population, continue to experience excess mortality regardless of having survived up to 15 years post-diagnosis. This gradual increase in excess mortality might result from the incurable nature of this disease characterized by multiple relapses throughout the disease course with limited efficacious treatment options in the released/refractory setting.

Original language	English
Pages (from-to)	1205-1208
Number of pages	4
Journal	British Journal of Haematology
Volume	196
Issue number	5
Early online date	4 Nov 2021
DOIs	https://doi.org/10.1111/bjh.17926
Publication status	Published - Mar 2022

Keywords

conditional relative survival
lymphoplasmacytic lymphoma
population-based
Waldenström’s macroglobulinaemia
Waldenstrom's macroglobulinaemia

Access to Document

10.1111/bjh.17926Licence: CC BY-NC-ND

Br J Haematol - 2021 - Amaador - Conditional relative survival in Waldenstr m s macroglobulinaemia a population‐basedFinal published version, 233 KBLicence: CC BY-NC-ND

Cite this

@article{75472ac6b4394006910fe787560d0084,

title = "Conditional relative survival in Waldenstr{\"o}m's macroglobulinaemia: a population-based study in The Netherlands",

abstract = "Contemporary diagnosed WM patients, compared to the general population, continue to experience excess mortality regardless of having survived up to 15 years post-diagnosis. This gradual increase in excess mortality might result from the incurable nature of this disease characterized by multiple relapses throughout the disease course with limited efficacious treatment options in the released/refractory setting.",

keywords = "conditional relative survival, lymphoplasmacytic lymphoma, population-based, Waldenstr{\"o}m{\textquoteright}s macroglobulinaemia, Waldenstrom's macroglobulinaemia",

author = "Karima Amaador and Kersten, \{Marie Jos{\'e}\} and Otto Visser and Posthuma, \{Eduardus F.M.\} and Minnema, \{Monique C.\} and Vos, \{Josephine M.I.\} and Dinmohamed, \{Avinash G.\}",

note = "Publisher Copyright: {\textcopyright} 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley \& Sons Ltd. Funding Information: The authors would like to thank the registration clerks of the Netherlands Cancer Registry (NCR) for their dedicated data collection. The nationwide population-based NCR is maintained and hosted by the Netherlands Comprehensive Cancer Organisation (IKNL). Publisher Copyright: {\textcopyright} 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley \& Sons Ltd.",

year = "2022",

month = mar,

doi = "10.1111/bjh.17926",

language = "English",

volume = "196",

pages = "1205--1208",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley \& Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Conditional relative survival in Waldenström's macroglobulinaemia

T2 - a population-based study in The Netherlands

AU - Amaador, Karima

AU - Kersten, Marie José

AU - Visser, Otto

AU - Posthuma, Eduardus F.M.

AU - Minnema, Monique C.

AU - Vos, Josephine M.I.

AU - Dinmohamed, Avinash G.

N1 - Publisher Copyright: © 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. Funding Information: The authors would like to thank the registration clerks of the Netherlands Cancer Registry (NCR) for their dedicated data collection. The nationwide population-based NCR is maintained and hosted by the Netherlands Comprehensive Cancer Organisation (IKNL). Publisher Copyright: © 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.

PY - 2022/3

Y1 - 2022/3

N2 - Contemporary diagnosed WM patients, compared to the general population, continue to experience excess mortality regardless of having survived up to 15 years post-diagnosis. This gradual increase in excess mortality might result from the incurable nature of this disease characterized by multiple relapses throughout the disease course with limited efficacious treatment options in the released/refractory setting.

AB - Contemporary diagnosed WM patients, compared to the general population, continue to experience excess mortality regardless of having survived up to 15 years post-diagnosis. This gradual increase in excess mortality might result from the incurable nature of this disease characterized by multiple relapses throughout the disease course with limited efficacious treatment options in the released/refractory setting.

KW - conditional relative survival

KW - lymphoplasmacytic lymphoma

KW - population-based

KW - Waldenström’s macroglobulinaemia

KW - Waldenstrom's macroglobulinaemia

UR - https://www.scopus.com/pages/publications/85118511234

U2 - 10.1111/bjh.17926

DO - 10.1111/bjh.17926

M3 - Article

C2 - 34738239

AN - SCOPUS:85118511234

SN - 0007-1048

VL - 196

SP - 1205

EP - 1208

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 5

ER -

Conditional relative survival in Waldenström's macroglobulinaemia: a population-based study in The Netherlands

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this